-
Second day of Powell’s hearings in Congress
-
Riksbank expected to leave rates unchanged
-
Cisco Systems and CVS Health among today’s earnings reporters
8:30 am GMT - Riksbank rate decision. Expected: 0.0%. Previous: 0.0%
10:00 am GMT - Euro area, industrial production for December. Expected: -2.3% YoY. Previous: -1.5% YoY
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app3:00 pm GMT - Jerome Powell testifies before the Senate Banking Committee. Fed Chair will head to Congress today for the second day of semi-annual testimonies. Powell said yesterday that the US economy is in a very good place and that Fed is closely monitoring coronavirus outbreak. Central banker said that he does not see recession on the horizon.
3:30 pm GMT - DOE report on oil inventories. API estimates released yesterday signalled a massive 6 million build in crude oil inventories. However, the oil market ignored this reading and kept marching higher as investors hope that Russia will express its willingness for deeper output cuts. Having said that, today’s release may be overlooked as well. Gasoline inventories are expected to increase while distillates should decline.
Asian session
11:50 pm GMT - Japan, PPI inflation for January. Expected: 1.5% YoY. Previous: 0.9% YoY
Central bankers’ speeches
-
9:50 am GMT - ECB’s Lane
-
10:00 am GMT - Riksbank’s post-decision press conference
-
1:30 pm GMT - Fed’s Harker
-
7:10 pm GMT - RBNZ Governor Orr
Major US earnings releases
-
Applied Materials (AMAT.US)
-
Bunge (BG.US)
-
Cisco Systems (CSCO.US)
-
Centurylink (CTL.US)
-
CVS Health (CVS.US)
-
Marathon Oil (MRO.US)
-
TripAdvisor (TRIP.US)
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
